{"id":"NCT01091675","sponsor":"Spanish Foundation of Rheumatology","briefTitle":"Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs","officialTitle":"Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis (AS) and Inadequate Response to ≥2 Nonsteroidal Antiinflammatory Drug (NSAID)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2013-05","completion":"2013-05","firstPosted":"2010-03-24","resultsPosted":"2015-06-10","lastUpdate":"2015-08-25"},"enrollment":58,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Ankylosing Spondylitis"],"interventions":[{"type":"DRUG","name":"Etoricoxib","otherNames":["Arcoxia"]}],"arms":[{"label":"etoricoxib","type":"EXPERIMENTAL"}],"summary":"The goal of this research is to assess the percentage of non-responders to ≥ 2 NSAIDs candidates a biological therapy that could adequately respond to treatment with etoricoxib This study confirm the result of a previous study in a wider similar population. Basing on previous results, the response rate will be assessed by ASASBIO criteria. The efficacy of the treatment with etoricoxib 90 mg will be assessed at week 4 in a population of patients with AS who didn't respond adequately to a previous therapy with ≥ 2 NSAIDs.\n\nThose patients that, based on the ASABIO criteria, achieved a sufficient clinical response will be followed until week 24 to asses the maintenance of the study drug effects.","primaryOutcome":{"measure":"the Percentage of Patients Fulfilling the Assessment Study (ASAS) Response Criteria Were Determined","timeFrame":"the ASAS response were evaluated at week 2 and 4 and after 6 months treatment","effectByArm":[{"arm":"Etoricoxib","deltaMin":19,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":14,"countries":["Spain"]},"refs":{"pmids":["15818702","18952641","12922952"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":57},"commonTop":["arterial hypertension","Tachycardia","headache","anxiety","Nervousness"]}}